Both Epacadostat and TCDD treatment led to activation of the AhR reporter (Supplementary Fig. 5d), upregulation of IDO1 expression (Supplementary Fig. 5e), and the nuclear translocation of AhR in both tumor cells and splenic T cells (Supplementary Fig. 5f–i). The gene discussed is IDO1; the disease is neoplasm.